Cite
HARVARD Citation
Steere, B. et al. (n.d.). OP28 Gene expression (GE) values in a phase 2 trial of mirikizumab in ulcerative colitis (UC) correlate better with histopathology (HP) than endoscopy (EN) and Mayo scores. Journal of Crohn's and colitis. pp. S025-S026. [Online].